{
    "data": [
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLXD5FC8F:0",
            "title": "BRIEF-NPK International Q3 Revenue USD 68.8 Million Vs. IBES Estimate USD 57.8 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div><span><p class=\"\"><span>Oct 30 (Reuters) - NPK International Q3 net income USD 5.654 million.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLXD5FC8F:0-brief-npk-international-q3-revenue-usd-68-8-million-vs-ibes-estimate-usd-57-8-million/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLXE5BA18:0",
            "title": "BRIEF-Invesco Mortgage Capital Q3 Net Income USD 50.2 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div><span><p class=\"\"><span>Oct 30 (Reuters) - Invesco Mortgage Capital Q3 net interest income USD 17.6 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 EPS USD 0.74</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLXE5BA18:0-brief-invesco-mortgage-capital-q3-net-income-usd-50-2-million/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX7201CD:0",
            "title": "BRIEF-Ingersoll Rand Q3 Pretax Profit USD 319.4 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Ingersoll Rand Q3 EPS USD 0.61.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 245.8 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 gross profit USD 855.2 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 revenue USD 1,955 million vs. IBES estimate USD 1,949 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 operating income USD 375.5 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 adjusted EBITDA USD 545 million vs. IBES estimate USD 540.6 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX7201CD:0-brief-ingersoll-rand-q3-pretax-profit-usd-319-4-million/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX8793CE:0",
            "title": "BRIEF-Houlihan Lokey Q2 EPS USD 1.63",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Houlihan Lokey Q2 EBIT USD 151.341 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q2 net income USD 111.781 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q2 revenue USD 659.452 million vs. IBES estimate USD 639.1 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q2 adjusted net income USD 127 million vs. IBES estimate USD 113.8 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX8793CE:0-brief-houlihan-lokey-q2-eps-usd-1-63/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX36375D:0",
            "title": "BRIEF-FTAI Infrastructure Q3 Adjusted EBITDA USD 70.931 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - FTAI Infrastructure Q3 operating expenses USD 74.985 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 revenue USD 140.556 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD -104.538 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 pretax profit USD -99.457 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX36375D:0-brief-ftai-infrastructure-q3-adjusted-ebitda-usd-70-931-million/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLXAEA47F:0",
            "title": "BRIEF-Employers Holdings Q3 EPS USD -0.36",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Employers Holdings Q3 revenue USD 183.9 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 net income ex LPT USD -9.6 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 EPS ex LPT USD -0.41 vs. IBES estimate USD 0.54</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD -8.3 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLXAEA47F:0-brief-employers-holdings-q3-eps-usd-0-36/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLXE54739:0",
            "title": "BRIEF-Cloudflare Q3 Revenue USD 562.027 Million Vs. IBES Estimate USD 544.8 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Cloudflare Q3 EPS USD 0.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD -1.29 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 adjusted EPS USD 0.27 vs. IBES estimate USD 0.23</span></li><li class=\"listItem-bmN0_SHH\"><span>CLOUDFLARE OUTLOOK Q4 REVENUE USD 588.5-589.5 MILLION</span></li><li class=\"listItem-bmN0_SHH\"><span>CLOUDFLARE OUTLOOK FY REVENUE USD 2,142-2,143 MILLION</span></li><li class=\"listItem-bmN0_SHH\"><span>CLOUDFLARE OUTLOOK FY ADJUSTED EPS USD 0.91</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLXE54739:0-brief-cloudflare-q3-revenue-usd-562-027-million-vs-ibes-estimate-usd-544-8-million/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX9D8920:0",
            "title": "BRIEF-Adtalem Global Education Q1 Revenue USD 462.3 Million Vs. IBES Estimate USD 452.3 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Adtalem Global Education Q1 adjusted EBITDA USD 112 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q1 net income USD 61.8 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX9D8920:0-brief-adtalem-global-education-q1-revenue-usd-462-3-million-vs-ibes-estimate-usd-452-3-million/",
            "pub_date": "2025-10-31 04:15:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX2C3C9D:0",
            "title": "BRIEF-Siriuspoint Q3 Net Income USD 85.2 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div><span><p class=\"\"><span>Oct 30 (Reuters) - Siriuspoint Q3 combined ratio 85.9%.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 core combined ratio 89.1%</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX2C3C9D:0-brief-siriuspoint-q3-net-income-usd-85-2-million/",
            "pub_date": "2025-10-31 04:15:48",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX3BE2EA:0",
            "title": "BRIEF-Plus Therapeutics Q3 Net Income USD -4.423 Million",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div><span><p class=\"\"><span>Oct 30 (Reuters) - Plus Therapeutics Q3 operating expenses USD 5.879 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 operating income USD -4.482 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX3BE2EA:0-brief-plus-therapeutics-q3-net-income-usd-4-423-million/",
            "pub_date": "2025-10-31 04:15:48",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX96B0F9:0",
            "title": "BRIEF-CubeSmart Q3 EPS USD 0.36",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - CubeSmart Q3 rental income USD 243.4 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 82.416 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 adjusted FFO USD 149 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX96B0F9:0-brief-cubesmart-q3-eps-usd-0-36/",
            "pub_date": "2025-10-31 04:15:48",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLXDFAB36:0",
            "title": "BRIEF-SB Financial Group Q3 EPS USD 0.64",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - SB Financial Group Q3 operating revenue USD 16.578 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 net interest income USD 12.334 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 4.046 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 provision for credit losses USD 124 thousand</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLXDFAB36:0-brief-sb-financial-group-q3-eps-usd-0-64/",
            "pub_date": "2025-10-31 04:15:50",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX166802:0",
            "title": "BRIEF-Gaming and Leisure Q3 Adjusted FFO USD 282 Million Vs. IBES Estimate USD 0.96",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div><span><p class=\"\"><span>Oct 30 (Reuters) - Gaming and Leisure Q3 revenue USD 397.6 million vs. IBES estimate USD 397.6 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 FFO USD 315.5 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 248.5 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 adjusted EBITDA USD 366.4 million vs. IBES estimate USD 368 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 operating income USD 337.2 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX166802:0-brief-gaming-and-leisure-q3-adjusted-ffo-usd-282-million-vs-ibes-estimate-usd-0-96/",
            "pub_date": "2025-10-31 04:15:50",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20251030015240_20251030015240:0",
            "title": "Artesian Resources 3Q EPS 68c >ARTNA",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20251030015240_20251030015240:0/",
            "pub_date": "2025-10-31 04:10:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tradingview:9043edf63fdc7:0",
            "title": "Acuity SVP & General Counsel Barry R Goldman Sells 4,489 Shares",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><span>Reporter Name</span></td><td><span>Goldman Barry R</span></td></tr><tr><td><span>Relationship</span></td><td><span>SVP &amp; General Counsel, 10% Owner</span></td></tr><tr><td><span>Type</span></td><td><span>Sell</span></td></tr><tr><td><span>Amount</span></td><td><span>$1,638,989</span></td></tr><tr><td><span>SEC Filing</span></td><td><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.sec.gov/Archives/edgar/data/1790061/000179006125000009/xslF345X05/wk-form4_1761854938.xml\" rel=\"nofollow\" target=\"_blank\">Form 4</a></td></tr></tbody></table></div><p class=\"\"><span>Barry R Goldman, SVP &amp; General Counsel and 10% owner at Acuity, sold 4,489 shares of Common Stock on October 28, 2025. The transactions were made at weighted average prices ranging from $362.18 to $370.46. The total sale amount was $1,638,989. Following these transactions, Goldman directly owns 6,056 shares of Acuity.</span></p><p class=\"\"><span>SEC Filing: </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.sec.gov/Archives/edgar/data/1790061/000179006125000009/xslF345X05/wk-form4_1761854938.xml\" rel=\"nofollow\" target=\"_blank\">ACUITY INC. (DE) [ AYI ] - Form 4 - Oct. 30, 2025</a></p></span></div></div>",
            "link": "https://www.tradingview.com/news/tradingview:9043edf63fdc7:0-acuity-svp-general-counsel-barry-r-goldman-sells-4-489-shares/",
            "pub_date": "2025-10-31 04:10:00",
            "source": "TradingView",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L1N3WB1HY:0",
            "title": "US stocks spooked by AI spending concerns, Powell's hawkish tone",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><div class=\"summary-cwMMKgmm\"><div class=\"summaryTitle-cwMMKgmm\">Key points:</div><span><ul class=\"list-bmN0_SHH\"><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Main US indexes end red; Nasdaq falls ~1.6%</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Cons Disc weakest S&amp;P 500 sector; Real Estate leads gainers</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>Dollar gains; gold up ~2.5%; crude slips; bitcoin loses ~4.5%</span></li><li class=\"listItem-bmN0_SHH listItem--lightning-bmN0_SHH\"><span>US 10-Year Treasury yield rises to ~4.09%</span></li></ul></span></div><span><p class=\"\"><span>US STOCKS SPOOKED BY AI SPENDING CONCERNS, POWELL'S HAWKISH TONE</span></p><p class=\"\"><span>U.S. stocks dropped on Thursday amid worries over surging AI spending, while investors also digested a more hawkish tone from the U.S. Federal Reserve.</span></p><p class=\"\"><span>Meanwhile, a widely anticipated trade agreement between U.S. President Donald Trump and Chinese President Xi Jinping appeared to do little to boost stocks on the day.</span></p><p class=\"\"><span>The Dow Jones Composite (.DJA) and the S&amp;P 500 Industrial sector </span><span> both hit record intraday highs, but couldn't hold their gains. Both ended down on the day.</span></p><p class=\"\"><span>Meta Platforms </span><span> shares plunged more than 11% after the social media company forecast \"notably larger\" capital expenses next year, thanks to investments in artificial intelligence.</span></p><p class=\"\"><span>Microsoft </span><span> dipped about 3% after the tech giant reported a record capital expenditure of nearly $35 billion for its fiscal first quarter and warned that spending would rise this year.</span></p><p class=\"\"><span>That said, Alphabet </span><span> rose 2.5% on Thursday as steady growth in the advertising business and cloud computing powered better-than-expected results.</span></p><p class=\"\"><span>Overall, the Magnificent Seven ETF </span><span> was an underperformer on the day, sliding 3.1%. Investors are focusing on quarterly numbers from two more members of the group as Apple </span><span> and Amazon.com </span><span> are reporting after the close. </span></p><p class=\"\"><span>The results followed the Federal Reserve's delivery on Wednesday of a widely expected quarter-point rate cut, before Chair Jerome Powell then raised doubts about future policy moves when in his press conference he said that a December cut was not a \"foregone conclusion.\"</span></p><p class=\"\"><span>The CME FedWatch Tool now puts the odds of a December rate cut at about 73% vs just over 90% one week ago.</span></p><p class=\"\"><span>In any event, despite the market's post-FOMC letdown, Craig Cohen, Managing Director, Global Investment Opportunities Group at J.P. Morgan pointed out Wednesday in a Market Intelligence Briefing that yesterday's rate cut was the fifth time that the Fed reduced its target rate with the S&amp;P 500 index </span><span> at all-time highs. </span></p><p class=\"\"><span>He notes that in all prior instances, the S&amp;P 500 was higher a year later with an average return of 20%. The worst one-year return was a 15% advance which occurred last year.</span></p><p class=\"\"><span>Here is a snapshot of where markets stood just shortly after 4 p.m. ET: </span></p><p class=\"\"><span>(Terence Gabriel)</span></p><p class=\"\"><span>     *****</span></p><p class=\"\"><span>EARLIER ON LIVE MARKETS:</span></p><p class=\"\"><span>OPTIONS TRADERS PRIMED FOR IMMENSE MARKET SWINGS WHEN THE S&amp;P 500 HITS 7,000 CLICK HERE</span></p><p class=\"\"><span>GIVEN FED'S UNEXPECTED TWISTS, US 10-YEAR YIELD MAY CONTORT HIGHER CLICK HERE</span></p><p class=\"\"><span>IS CHINA'S EM OUTPERFORMANCE ERA OVER? CAPITAL ECONOMICS SAYS YES CLICK HERE</span></p><p class=\"\"><span>S&amp;P 500, NASDAQ DOWN AS SOME BIG TECH EARNINGS FAIL THE HYPE CLICK HERE</span></p><p class=\"\"><span>MOMENTUM IS THE LEADER, BUT GROWTH HOT ON ITS HEELS CLICK HERE</span></p><p class=\"\"><span>CREDIT MARKETS KEY TO FUNDING $1.5-TRLN DATA CENTRE BUILDOUT - MS CLICK HERE</span></p><p class=\"\"><span>AI CAPEX BOOM: CITI SEES INFLECTION POINT CLICK HERE</span></p><p class=\"\"><span>WHAT IF THE US DATA BLACKOUT SUPPORTS BETS ON A DOVISH FED? CLICK HERE</span></p><p class=\"\"><span>STOXX DIPS CLICK HERE</span></p><p class=\"\"><span>BEFORE THE BELL: FUTURES FLAT, MIXED TECH, HEAVY EARNINGS DAY CLICK HERE</span></p><p class=\"\"><span>'AMAZING' TRUMP-XI MEETING COOLS TENSIONS CLICK HERE </span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3WB1HY:0-us-stocks-spooked-by-ai-spending-concerns-powell-s-hawkish-tone/",
            "pub_date": "2025-10-31 04:10:13",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L1N3WB1LS:0",
            "title": "Amazon beats Q3 net sales, EPS estimates",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Amazon Q3 2025 net sales grow 13% yr/yr, beating analysts' expectations, driven by AWS and international segments</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EPS for Q3 beats consensus, reflecting strong operational performance</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company's operating income impacted by special charges, net income rises significantly</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Amazon expects Q4 2025 net sales between $206.0 bln and $213.0 bln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company anticipates Q4 2025 operating income between $21.0 bln and $26.0 bln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Amazon's guidance includes a favorable FX impact of 190 basis points</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>AWS GROWTH - AWS sales increased 20% yr/yr, driven by strong demand for AI and core infrastructure, according to CEO Andy Jassy</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>INTERNATIONAL SALES - International segment sales rose 14% yr/yr, aided by favorable foreign exchange rates</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SPECIAL CHARGES - Operating income impacted by $2.5 bln legal settlement and $1.8 bln severance costs</span></p></li></ul><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Net Sales</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$180.17 bln</span></p></td><td><p class=\"\"><span>$177.75 bln (53 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 EPS</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$1.95</span></p></td><td><p class=\"\"><span>$1.57 (49 Analysts)</span></p></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 71 \"strong buy\" or \"buy\", 1 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the department stores peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Amazon.com Inc is $265.00, about 13.1% above its October 29 closing price of $230.30</span></p></li></ul><p class=\"\"><span>Press Release: </span></p><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:refinitivnewssupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3WB1LS:0-amazon-beats-q3-net-sales-eps-estimates/",
            "pub_date": "2025-10-31 04:10:33",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L1N3WB1M4:0",
            "title": "Weave Communications Q3 revenue beats estimates",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Weave Q3 2025 revenue grows 17.1% yr/yr, beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company achieved non-GAAP profitability and increased free cash flow</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Launched new payment features to enhance customer engagement and efficiency</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Weave expects Q4 revenue between $62.4 mln and $63.4 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company forecasts full-year revenue of $238 mln to $239 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Weave projects Q4 non-GAAP income from operations of $1.5 mln to $2.5 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company anticipates full-year non-GAAP income from operations of $3.3 mln to $4.3 mln</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>PAYMENT FEATURES - Launched new surcharging and bulk payment features to address customer needs and improve efficiency</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>PRODUCT ADVANCEMENTS - Significant advancements across product roadmap contributed to revenue growth, per CEO Brett White</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SMB HEALTHCARE FOCUS - Co's expertise and scale in SMB healthcare market seen as advantage in evolving tech landscape</span></p></li></ul><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Revenue</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$61.34 mln</span></p></td><td><p class=\"\"><span>$60.67 mln (6 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 EPS</span></p></td><td></td><td><p class=\"\"><span>-$0.11</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Adjusted Net Income</span></p></td><td></td><td><p class=\"\"><span>$2 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Net Income</span></p></td><td></td><td><p class=\"\"><span>-$8.66 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Gross Profit</span></p></td><td></td><td><p class=\"\"><span>$44.34 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy\", 2 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the software peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Weave Communications Inc is $12.00, about 45.2% above its October 29 closing price of $6.58</span></p></li></ul><p class=\"\"><span>Press Release: </span></p><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:refinitivnewssupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3WB1M4:0-weave-communications-q3-revenue-beats-estimates/",
            "pub_date": "2025-10-31 04:10:35",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L1N3WB1LX:0",
            "title": "Dexcom Q3 revenue up 22%, beats estimates, lifts 2025 revenue forecast",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Dexcom Q3 2025 revenue grows 22% yr/yr, beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EPS for Q3 2025 beats analyst expectations, reflecting positive operational performance</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company raises fiscal year 2025 revenue guidance, indicating confidence in continued growth</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Dexcom raises 2025 revenue guidance to $4.630-$4.650 bln, reflecting 15% growth</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company expects 2025 non-GAAP gross profit margin of approximately 61%</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Dexcom anticipates 2025 adjusted EBITDA margin of 29-30%</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>AI-POWERED FEATURE - Launched AI-powered meal logging in Stelo and Dexcom G7 app, enhancing personalized glucose insights</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>EXPANDED ACCESS - Expanded access to Dexcom G7 for insulin users under Ontario Drug Benefit Program in Canada</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>STRATEGIC INITIATIVES - Submitted Dexcom Smart Basal insulin titration module to FDA, aiming to enhance product offerings</span></p></li></ul><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Revenue</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$1.21 bln</span></p></td><td><p class=\"\"><span>$1.17 bln (25 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Adjusted EPS</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$0.61</span></p></td><td><p class=\"\"><span>$0.56 (24 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Adjusted Net Income</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$242.50 mln</span></p></td><td><p class=\"\"><span>$226.76 mln (18 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Adjusted Operating Income</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$272.90 mln</span></p></td><td><p class=\"\"><span>$271.25 mln (21 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Adjusted Gross Profit</span></p></td><td></td><td><p class=\"\"><span>$741.30 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Gross Profit</span></p></td><td></td><td><p class=\"\"><span>$731.40 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Operating Income</span></p></td><td></td><td><p class=\"\"><span>$242.50 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 25 \"strong buy\" or \"buy\", 5 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the medical equipment, supplies &amp; distribution peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Dexcom Inc is $100.00, about 31.8% above its October 29 closing price of $68.18</span></p></li></ul><p class=\"\"><span>Press Release: </span></p><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:refinitivnewssupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3WB1LX:0-dexcom-q3-revenue-up-22-beats-estimates-lifts-2025-revenue-forecast/",
            "pub_date": "2025-10-31 04:10:35",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLXA02BFF:0",
            "title": "BRIEF-Republic Services Q3 Adjusted EPS USD 1.9 Vs. IBES Estimate USD 1.78",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Republic Services Q3 revenue USD 4,212 million vs. IBES estimate USD 4,254 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 EPS USD 1.76</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 550 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 adjusted net income USD 594 million vs. IBES estimate USD 555.7 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLXA02BFF:0-brief-republic-services-q3-adjusted-eps-usd-1-9-vs-ibes-estimate-usd-1-78/",
            "pub_date": "2025-10-31 04:10:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX2654EC:0",
            "title": "BRIEF-Park Hotels & Resorts Q3 Adjusted FFO Per Share USD 0.35",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div><span><p class=\"\"><span>Oct 30 (Reuters) - Park Hotels &amp; Resorts Q3 adjusted revpar USD 180.93.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 EPS USD -0.08</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD -14 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX2654EC:0-brief-park-hotels-resorts-q3-adjusted-ffo-per-share-usd-0-35/",
            "pub_date": "2025-10-31 04:10:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX45B27E:0",
            "title": "BRIEF-Artesian Resources Q3 EPS USD 0.68",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Artesian Resources Q3 water sales USD 24.837 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 6.962 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 utility operating expenses USD 13.431 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 operating income USD 8.619 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 basic EPS USD 0.68</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX45B27E:0-brief-artesian-resources-q3-eps-usd-0-68/",
            "pub_date": "2025-10-31 04:10:46",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L1N3WB1L8:0",
            "title": "Programming and security service provider Data I/O Q3 sales miss estimates",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Data I/O Q3 2025 sales miss analyst expectations, unchanged from Q3 2024</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company bookings grow over 7% yr/yr, driven by PSV7000 demand</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Net loss in Q3 2025 increases compared to Q3 2024</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company plans to expand into programming services and embedded applications</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Data I/O invests in technology to support semiconductor growth strategies</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company poised for capital equipment refresh due to aging systems</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>BOOKINGS GROWTH - Driven by demand for PSV7000 Automated Programming System, bookings increased over 7% yr/yr</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>TECH SPENDING REALIGNMENT - Co cites temporary realignment of tech spending, impacting sales, with focus on AI investments and EV manufacturing reassessment</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>STRATEGIC PROGRESS - Enhancements to programming solutions and brand strengthening cited as strategic progress</span></p></li></ul><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Sales</span></p></td><td><p class=\"\"><span>Miss</span></p></td><td><p class=\"\"><span>$5.39 mln</span></p></td><td><p class=\"\"><span>$5.60 mln (2 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 EPS</span></p></td><td></td><td><p class=\"\"><span>-$0.15</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Net Income</span></p></td><td></td><td><p class=\"\"><span>-$1.36 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"strong buy\" and the breakdown of recommendations is 2 \"strong buy\" or \"buy\", no \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the computer hardware peer group is \"buy.\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Data I/O Corp is $5.61, about 44.6% above its October 29 closing price of $3.11</span></p></li></ul><p class=\"\"><span>Press Release: </span></p><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:refinitivnewssupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3WB1L8:0-programming-and-security-service-provider-data-i-o-q3-sales-miss-estimates/",
            "pub_date": "2025-10-31 04:10:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX071C66:0",
            "title": "BRIEF-The Bancorp Q3 EPS USD 1.18",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - The Bancorp Q3 net interest income USD 94.197 million.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 provision for credit losses USD 5.755 million</span></li><li class=\"listItem-bmN0_SHH\"><span>Q3 net income USD 54.927 million</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX071C66:0-brief-the-bancorp-q3-eps-usd-1-18/",
            "pub_date": "2025-10-31 04:10:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025-10-30:newsml_PLX810ED4:0",
            "title": "BRIEF-Motorola Q3 Adjusted EPS USD 4.06 Vs. IBES Estimate USD 3.85",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Oct 30 (Reuters) - Motorola Q3 EPS USD 3.33.</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Q3 sales USD 3,009 million vs. IBES estimate USD 2,988 million</span></li><li class=\"listItem-bmN0_SHH\"><span>MOTOROLA Q3 NET INCOME USD 562 MILLION</span></li><li class=\"listItem-bmN0_SHH\"><span>outlook Q4 revenue growth 11%</span></li><li class=\"listItem-bmN0_SHH\"><span>outlook FY revenue USD 11,650 million</span></li><li class=\"listItem-bmN0_SHH\"><span>MOTOROLA OUTLOOK FY ADJUSTED EPS USD 15.09-15.15</span></li><li class=\"listItem-bmN0_SHH\"><span>MOTOROLA OUTLOOK Q4 ADJUSTED EPS USD 4.3-4.36</span></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025-10-30:newsml_PLX810ED4:0-brief-motorola-q3-adjusted-eps-usd-4-06-vs-ibes-estimate-usd-3-85/",
            "pub_date": "2025-10-31 04:10:47",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2025:newsml_L1N3WB1LZ:0",
            "title": "Gilead Sciences Q3 adjusted EPS beats estimates helped by higher demand for HIV products",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Gilead Q3 2025 total revenue rises 3% yr/yr to $7.8 bln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EPS for Q3 2025 beats analyst expectations, per LSEG data</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Product sales excluding Veklury increase 4% to $7.1 bln</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Gilead raises full-year product sales guidance to $28.4 bln-$28.7 bln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company increases full-year diluted EPS guidance to $6.65-$6.85</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Gilead anticipates multiple product launches in 2026</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>HIV SALES - HIV product sales increased 4% to $5.3 bln, driven by higher demand and favorable inventory dynamics, though offset by lower average realized price</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>LIVER DISEASE SALES - Liver Disease portfolio sales rose 12% to $819 mln, mainly due to higher demand for Livdelzi</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>VEKLURY DECLINE - Veklury sales dropped 60% to $277 mln, attributed to lower COVID-19-related hospitalizations</span></p></li></ul><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q3 Product Sales</span></p></td><td></td><td><p class=\"\"><span>$7.34 bln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q3 Adjusted EPS</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$2.47</span></p></td><td><p class=\"\"><span>$2.13 (19 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q3 EPS</span></p></td><td></td><td><p class=\"\"><span>$2.43</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 23 \"strong buy\" or \"buy\", 7 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the pharmaceuticals peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Gilead Sciences Inc is $131.00, about 9.5% above its October 29 closing price of $118.50</span></p></li></ul><p class=\"\"><span>Press Release: </span></p><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:refinitivnewssupport@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">RefinitivNewsSupport@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2025:newsml_L1N3WB1LZ:0-gilead-sciences-q3-adjusted-eps-beats-estimates-helped-by-higher-demand-for-hiv-products/",
            "pub_date": "2025-10-31 04:10:52",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tradingview:fea249ad9b5a0:0",
            "title": "Key facts: Carlyle Group to report earnings; expects 10.3% revenue growth",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Carlyle Group (CG) will report earnings this Friday, with analysts expecting 10.3% revenue growth to about $987.3 million and adjusted earnings of $1.02 per share.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/stockstory:51a5ea8e8094b:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">1</span></a></li><li class=\"listItem-bmN0_SHH\"><span>Carlyle Group joined the Abu Dhabi Global Market (ADGM) community in 2025, enhancing ADGM's status as a prominent financial center for global investment firms.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/reuters.com,2025-10-30:newsml_Zaw1kbRBt:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">2</span></a></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/tradingview:fea249ad9b5a0:0-key-facts-carlyle-group-to-report-earnings-expects-10-3-revenue-growth/",
            "pub_date": "2025-10-31 04:05:22",
            "source": "TradingView",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tradingview:448abd66fbb3b:0",
            "title": "Key facts: CVS Health Q3 sales rise 7.8%; price targets increased; $5.7B write-down",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>CVS Health's Q3 2025 earnings showed sales of $102.9 billion, up 7.8% year-on-year, with adjusted EPS of $1.61, surpassing estimates by 18.3%. Full-year EPS guidance raised to $6.60.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/stockstory:185890ad9094b:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">1</span></a></li><li class=\"listItem-bmN0_SHH\"><span>Several financial firms have boosted their price targets for CVS Health, with Evercore ISI raising it to $95, RBC Capital to $93, and Cantor Fitzgerald to $95.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/DJN_DN20251030010847:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">2</span></a></li><li class=\"listItem-bmN0_SHH\"><span>CVS Health announced a $5.7 billion write-down linked to its Oak Street Health acquisition, underscoring ongoing profitability issues since Oak Street's 2020 IPO.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/DJN_DN20251029012415:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">3</span></a></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/tradingview:448abd66fbb3b:0-key-facts-cvs-health-q3-sales-rise-7-8-price-targets-increased-5-7b-write-down/",
            "pub_date": "2025-10-31 04:05:22",
            "source": "TradingView",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tradingview:cec284f9cbdce:0",
            "title": "Key facts: Bristol Myers Squibb Q3 Sales Up 7% to $2.53 Billion; Stock Rises 5.39%",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>Bristol Myers Squibb reported a 7% increase in sales of its cancer drug Opdivo, reaching $2.53 billion, bolstered by a new injectable version that added $67 million, exceeding analysts' expectations.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/reuters.com,2025:newsml_L4N3WB2CX:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">1</span></a></li><li class=\"listItem-bmN0_SHH\"><span>On October 30, 2025, Bristol Myers Squibb reported its Q3 financial results and will hold a conference call for analysts and investors at 8:00 a.m. ET.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/DJN_DN20251030006019:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">2</span></a></li><li class=\"listItem-bmN0_SHH\"><span>Bristol-Myers Squibb Company (BMY) is trading at $44.90, having increased by $2.30 or 5.39%, marking the company's largest percent increase since November 11, 2024.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/DJN_DN20251030013308:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">3</span></a></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/tradingview:cec284f9cbdce:0-key-facts-bristol-myers-squibb-q3-sales-up-7-to-2-53-billion-stock-rises-5-39/",
            "pub_date": "2025-10-31 04:05:22",
            "source": "TradingView",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tradingview:efe884fec67bf:0",
            "title": "Key facts: BorgWarner Q3 Earnings Rise; Warns of Production Halts",
            "description": "<div class=\"body-KX2tCBZq body-pIO_GYwT content-pIO_GYwT\"><div class=\"symbolsContainer-cBh_FN2P logosContainer-cwMMKgmm\" data-no-swipe=\"true\"></div><div><span><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><span>BorgWarner Inc. reported Q3 2025 adjusted earnings of $1.24 per share, up from $1.09 last year. Net sales reached $3.59 billion, a 4.1% year-over-year increase.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/DJN_DN20251030004652:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">1</span></a><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/reuters.com,2025-10-30:newsml_PLXDC8632:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">2</span></a></li><li class=\"listItem-bmN0_SHH\"><span>BorgWarner Inc. warns of possible production halts due to supply issues with Nexperia and a fire at Novelis, expecting a $50 million to $100 million impact in Q4.</span><a class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" data-exclude-from-news-link-analytics=\"true\" href=\"/news/reuters.com,2025:newsml_L4N3WB2F1:0\" target=\"_blank\"><span class=\"text-Jww2aqrB\">3</span></a></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/tradingview:efe884fec67bf:0-key-facts-borgwarner-q3-earnings-rise-warns-of-production-halts/",
            "pub_date": "2025-10-31 04:05:22",
            "source": "TradingView",
            "kind": 1,
            "language": "en"
        }
    ]
}